US$ 28.83
ipamorelin clinical studies benefits cjc-1295 CJC 1295 Ipamorelin: The of Peptide Therapy CJC-1295/Ipamorelin Benefits, Side Effects, and
Description
Oertel and Schulz, 2016

For MuRF1, myosin heavy chain (MYH) was identified as its target in Dex-induced myotube atrophy model [42]

Skeletal muscle atrophy: from mechanisms to treatments
10.1002/cbf.3163 44 Macias-BarraganJ.Huerta-OlveraS